IVMD Announces Agreement on Diagnostic Product for Schizophrenia

In Veritas announced it has signed a commercial agreement on a joint project with The Ness Foundation, a Scottish based neuro-developmental research organization. IVMD will apply its patented, low cost, measurement systems together with The Ness Foundation's intellectual property to develop a rapid, low cost, non-invasive diagnostic product for the early and effective detection of mental illness. The joint development will focus in the area of phospholipid spectrum disorders and the breakdown in communication between brain cells to evaluate simple, quantitative and diagnostic tests.

()a href="http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050601005483&newsLang=en" target="_blank">Business Wire